Fezagepras

SKU: orb1309110

Description

Fezagepras (Setogepram) is an orally bioavailable small molecule that acts as a GPR40 agonist and a GPR84 antagonist/inverse agonist. It exhibits anti-inflammatory, anti-fibrotic, and anti-proliferative properties, making it a useful research tool for studying metabolic and inflammatory diseases in both in vitro and in vivo models.

Research Area

Metabolism Research, Pharmacology & Drug Discovery

Key Properties

• CAS Number: 1002101-19-0
• MW: 206.28
• Purity: 96.73% (May vary between batches)
• Formula: C₁₃H₁₈O₂
• SMILES: CCCCCc1cccc(CC(O)=O)c1
• Target: GPCR
• Solubility: DMSO:60 mg/mL (290.87 mM);10% DMSO+90% Saline:5 mg/mL (24.24 mM)

Storage & Handling

• Storage: -20°C
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Alternative Names

Diabetes,Kidney,Renal,Pancreatic,Liver,Fibrosis,Nephrology, inhibit, PBI4050, PBI-4050, PBI 4050, Inhibitor, G protein coupled receptor 84, Free Fatty Acid Receptor, Fezagepras, FFAR, GPR40, GPR84, Setogepram

Quick Database Links

Gene Symbol

GPCR